HC Wainwright has raised its price target on BioXcel Therapeutics (NASDAQ:BTAI) to
According to a report on Tuesday by The Fly, HC Wainwright lowered its price objective for ...
Read moreAccording to a report on Tuesday by The Fly, HC Wainwright lowered its price objective for ...
Read moreCARLSBAD, Calif., July 13, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management ...
Read more© 2022 TheDailyStock.News